Pharmacy Grand Rounds 
Giving It Our Best Shot: Pharmacy-Driven Initiatives to Enhance COVID-19 Immunization Efforts

• ACPE Universal Activity Number (UAN): JA0000238-0000-21-004-L01-P
• Session Type: Knowledge-based
• CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
  • AAPA Category 1 CME Credits
  • ACPE
  • AMA PRA Category 1 Credits™
  • ANCC

• Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST) 

Until further notice, learners must watch Pharmacy Grand Rounds live via the web by going to the Video Exchange and selecting “Pharmacy Grand Rounds” in the “Streaming Now” section.

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

In December 2020, the FDA authorized Pfizer’s COVID-19 vaccine for emergency use, followed only weeks later by emergency authorization for a different COVID-19 vaccine produced by Moderna. The new mRNA vaccine technology, public demand for immunizations, and scale of COVID-19 immunization efforts have presented significant challenges that have been overcome through concentrated efforts from organizations and pharmacy departments.  During this session pharmacy-related COVID-19 immunization challenges and solutions will be discussed, along with challenges we can expect to see in the ever-changing landscape of the COVID-19 pandemic. 

LEARNING OBJECTIVES
At the conclusion of this knowledge-based CE session, participants should be able to:

• List three differences between COVID-19 immunization efforts and previous mass immunization strategies.
• Describe challenges in complying with vaccine delivery, storage, and administration processes required by FDA emergency use authorization.
• Summarize the current state and future directions of COVID-19 mass immunization efforts.

Session Announcement

FACULTY INFORMATION

Kellyn K. Engstrom, PharmD, MPH
PGY2 Emergency Medicine Pharmacy Resident
Mayo Clinic Hospital - Rochester, MN

Kellyn received a Doctor of Pharmacy degree and Master of Public Health degree from the University of Wisconsin-Madison.  She completed a PGY1 Pharmacy Residency and is the current PGY-2 Emergency Medicine pharmacy resident at Mayo Clinic Hospital – Rochester. She has practice interests in emergency medicine, critical care, pain management, and public health. 

DISCLOSURE STATEMENTS
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

• Kellyn K. Engstrom, PharmD, MPH
  • Declares no financial relationship(s) pertinent to this session
  • Declares off-label use of devices and medications will not be discussed during this presentation

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session. 

Members include:

• Jennifer Elmer, DNP, APRM, CCNS, FCCM
• Michael Huckabee, MPAS, PA-C, PhD
• Sarah Jane Kotval, BSW
• Wayne (Nick) Nicholson, MD, PharmD, BCPS
• Garrett Schramm, PharmD, BCPS
• Lee Skrupky, PharmD, BCPS
• Brenda Stellmaker